{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T21:24:15Z","timestamp":1705613055548},"reference-count":23,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Actas Urol\u00f3gicas Espa\u00f1olas"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.acuro.2013.02.013","type":"journal-article","created":{"date-parts":[[2013,7,11]],"date-time":"2013-07-11T21:15:12Z","timestamp":1373577312000},"page":"34-40","source":"Crossref","is-referenced-by-count":5,"title":["Manejo de la ginecomastia en pacientes con c\u00e1ncer de pr\u00f3stata y deprivaci\u00f3n androg\u00e9nica"],"prefix":"10.1016","volume":"38","author":[{"given":"C.","family":"Bautista-Vidal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Barnoiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Garc\u00eda-Galisteo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"G\u00f3mez-Lechuga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Baena-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.acuro.2013.02.013_bib0005","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.acuro.2011.03.011","article-title":"Gu\u00eda de la EAU sobre el c\u00e1ncer de pr\u00f3stata. Parte II: tratamiento del c\u00e1ncer de pr\u00f3stata avanzado, recidivante y resistente a la castraci\u00f3n","volume":"35","author":"Mottet","year":"2011","journal-title":"Actas Urol Esp"},{"key":"10.1016\/j.acuro.2013.02.013_bib0010","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1056\/NEJMcp070677","article-title":"Gyneacomastia","volume":"357","author":"Braunstein","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acuro.2013.02.013_bib0015","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/sj.pcan.4500314","article-title":"Gyneacomastia: Aetiology and treatment options","volume":"2","author":"Tyrrel","year":"1999","journal-title":"Prostate Cancer Prost Dis"},{"key":"10.1016\/j.acuro.2013.02.013_bib0020","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.acuro.2011.09.006","article-title":"Impacto de la supresi\u00f3n androg\u00e9nica sobre el perfil lip\u00eddico y el riesgo aterog\u00e9nico en pacientes con c\u00e1ncer de pr\u00f3stata","volume":"36","author":"Salvador","year":"2012","journal-title":"Actas Urol Esp"},{"key":"10.1016\/j.acuro.2013.02.013_bib0025","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/S1470-2045(05)70464-2","article-title":"Management of gynaecomastia in patients with prostate cancer: A systematic review","volume":"6","author":"Di Lorenzo","year":"2005","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.acuro.2013.02.013_bib0030","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1159\/000185497","article-title":"Gynecomastia: Pathomechanisms and treatment strategies","volume":"48","author":"Marthur","year":"1997","journal-title":"Horm Res"},{"key":"10.1016\/j.acuro.2013.02.013_bib0035","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0090-4295(00)00823-2","article-title":"Gynecomastia in patients with prostate cancer: a review of treatment options","volume":"56","author":"McLeod","year":"2000","journal-title":"Urology"},{"key":"10.1016\/j.acuro.2013.02.013_bib0040","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1097\/01.ju.0000176461.75794.f8","article-title":"Incidence of management of gynecomastia in men treated for prostate cancer","volume":"174","author":"Dobs","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.acuro.2013.02.013_bib0045","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1111\/j.1464-410X.2010.09319.x","article-title":"Antiandrogen monotherapy in patients with localized or locally advanced prostate cancer: Final results from Bicalutamide Early Prostate Cancer programme at a medium follow-up of 9,7 years","volume":"105","author":"Iversen","year":"2010","journal-title":"BJU Int"},{"key":"10.1016\/j.acuro.2013.02.013_bib0050","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1097\/01.ju.0000140159.94703.80","article-title":"Bicalutamide 150mg in addition to standard care in patients with localized or locally advanced prostate cancer: results from the second analysis of the early prostate cancer program at medium follow-up of 5,4 years","volume":"172","author":"Wirth","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.acuro.2013.02.013_bib0055","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S1470-2045(03)00958-6","article-title":"The safety and tolerability of low-dose irradiation for the management of gynecomastia caused by anti-androgen monotherapy","volume":"4","author":"Dicker","year":"2003","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.acuro.2013.02.013_bib0060","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.eururo.2004.12.003","article-title":"Efficacy and tolerability of radiotherapy as treatment for bicalutamide-induced gynecomastia and breast pain in prostate cancer","volume":"47","author":"Van Poppel","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuro.2013.02.013_bib0065","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.ijrobp.2004.03.022","article-title":"Prophylactic breast irradiation with a single dose of electron beam radiotherapy (10Gy) significantly reduces the incidence of bicalutamide-induced gynecomastia","volume":"60","author":"Tyrrell","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.acuro.2013.02.013_bib0070","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1097\/01.ju.0000181824.28382.5c","article-title":"Gynecomastia and breast pain induced by adjuvant therapy with bicalutamide after radical prostatectomy in patients with prostate cancer: The role of tamoxifen and radiotherapy","volume":"174","author":"Di Lorenzo","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.acuro.2013.02.013_bib0075","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S1470-2045(05)70103-0","article-title":"Efficacy of tamoxifen and radiotherapy for prevention and treatment of gynecomastia and breast pain caused by bicalutamide in prostate cancer: a randomized controlled trial","volume":"6","author":"Perdona","year":"2005","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.acuro.2013.02.013_bib0080","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0090-4295(02)02107-6","article-title":"Does prophylactic breast irradiation prevent antiandrogen-induced gynecomastia? Evaluation of 253 patients in the randomized Scandinavian trial SPCG-7\/SFUO-3","volume":"61","author":"Widmark","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.acuro.2013.02.013_bib0085","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/0360-3016(88)90321-5","article-title":"Effective radiotherapy in palliating mammalgia associated with gynecomastia after DES therapy","volume":"15","author":"Chou","year":"1988","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.acuro.2013.02.013_bib0090","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.juro.2010.03.137","article-title":"Is prophylactic breast radiotherapy necessary in all patients with prostate cancer and Gynecomastia and\/or breast pain?","volume":"184","author":"Ozen","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.acuro.2013.02.013_bib0095","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.urology.2006.08.319","article-title":"Tamoxifen as prophylaxis for prevention of gynecomastia and breast pain associated with bicalutamide 150 mg monotherapy in patients with prostate cancer","volume":"68","author":"Fradet","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.acuro.2013.02.013_bib0100","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.eururo.2009.05.019","article-title":"An open, randomised, multicentre, phase 3 trial comparing the efficacy of two tamoxifen schedules in preventing gynecomastia induced by bicalutamide monotherapy in prostate cancer patients","volume":"57","author":"Bedognetti","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuro.2013.02.013_bib0105","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1200\/JCO.2005.12.013","article-title":"Evaluation of tamoxifen and anastrozole in the prevention of gynecomastia and breast pain induced by bicalutamide monotherapy of prostate cancer","volume":"23","author":"Boccardo","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.acuro.2013.02.013_bib0110","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/1741-7015-10-96","article-title":"Tamoxifen for the management of breast events induced by non-steroidal antiandrogens in patients with prostate cancer: a systematic review","volume":"10","author":"Kunath","year":"2012","journal-title":"BMC Med"},{"key":"10.1016\/j.acuro.2013.02.013_bib0115","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/sj.pcan.4500782","article-title":"Prevention and management of bicalutamide-induced gynecomastia and breast pain: randomized endocrinologic and clinical studies with tamoxifen and anastrozole","volume":"8","author":"Saltzstein","year":"2005","journal-title":"Prostate Cancer Prostatic Dis"}],"container-title":["Actas Urol\u00f3gicas Espa\u00f1olas"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210480613000983?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210480613000983?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,14]],"date-time":"2018-10-14T16:58:34Z","timestamp":1539536314000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0210480613000983"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0210480613000983"],"URL":"https:\/\/doi.org\/10.1016\/j.acuro.2013.02.013","relation":{},"ISSN":["0210-4806"],"issn-type":[{"value":"0210-4806","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]}}}